Adoptive T Cell Therapy for Epstein–Barr Virus Complications in Patients With Primary Immunodeficiency Disorders

Patients with primary immunodeficiency disorders (PID) have an increased risk from acute and chronic Epstein–Barr Virus (EBV) viral infections and EBV-associated malignancies. Hematopoietic stem cell transplantation (HSCT) is a curative strategy for many patients with PID, but EBV-related complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Lauren P., Bollard, Catherine M., Keller, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867312/
https://www.ncbi.nlm.nih.gov/pubmed/29616044
http://dx.doi.org/10.3389/fimmu.2018.00556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867312/
https://www.ncbi.nlm.nih.gov/pubmed/29616044
http://dx.doi.org/10.3389/fimmu.2018.00556

Ejemplares similares